Agilent collaborator takes an integrated, multi-omics spproach to metabolism
27 January 2020

Adam Rosebrock was feeling unsettled. For years he had been using genomics to study what cells do when they do, well … what cells do. That is, which genes turn on or off as they go through cell division, for example, or various external insults. Simply put, he was not getting enough information. So Rosebrock, a classically trained microbiologist and biochemist, began to expand the scope of his investigation